414 related articles for article (PubMed ID: 34298815)
1. Lineage Plasticity in Cancer: The Tale of a Skin-Walker.
Thankamony AP; Subbalakshmi AR; Jolly MK; Nair R
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298815
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.
Jayachandran A; Dhungel B; Steel JC
J Hematol Oncol; 2016 Aug; 9(1):74. PubMed ID: 27578206
[TBL] [Abstract][Full Text] [Related]
3. Cell Plasticity and Prostate Cancer: The Role of Epithelial-Mesenchymal Transition in Tumor Progression, Invasion, Metastasis and Cancer Therapy Resistance.
Papanikolaou S; Vourda A; Syggelos S; Gyftopoulos K
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199763
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNAs in lung cancer: implications for lineage plasticity-mediated TKI resistance.
Liu T; Han C; Fang P; Zhu H; Wang S; Ma Z; Zhang Q; Xia W; Wang J; Xu L; Yin R
Cell Mol Life Sci; 2021 Mar; 78(5):1983-2000. PubMed ID: 33170304
[TBL] [Abstract][Full Text] [Related]
5. Lineage switching in acute leukemias: a consequence of stem cell plasticity?
Dorantes-Acosta E; Pelayo R
Bone Marrow Res; 2012; 2012():406796. PubMed ID: 22852088
[TBL] [Abstract][Full Text] [Related]
6. Lineage plasticity in cancer: a shared pathway of therapeutic resistance.
Quintanal-Villalonga Á; Chan JM; Yu HA; Pe'er D; Sawyers CL; Sen T; Rudin CM
Nat Rev Clin Oncol; 2020 Jun; 17(6):360-371. PubMed ID: 32152485
[TBL] [Abstract][Full Text] [Related]
7. Understanding Lineage Plasticity as a Path to Targeted Therapy Failure in
Shaurova T; Zhang L; Goodrich DW; Hershberger PA
Front Genet; 2020; 11():281. PubMed ID: 32292420
[TBL] [Abstract][Full Text] [Related]
8. Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma.
van der Horst G; Bos L; van der Pluijm G
Mol Cancer Res; 2012 Aug; 10(8):995-1009. PubMed ID: 22714124
[TBL] [Abstract][Full Text] [Related]
9. Communication Between Epithelial-Mesenchymal Plasticity and Cancer Stem Cells: New Insights Into Cancer Progression.
Zheng X; Dai F; Feng L; Zou H; Feng L; Xu M
Front Oncol; 2021; 11():617597. PubMed ID: 33968721
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer cells: Focus on the consequences of epithelial-to-mesenchymal transition.
Bong AHL; Monteith GR
Int J Biochem Cell Biol; 2017 Jun; 87():23-26. PubMed ID: 28336365
[TBL] [Abstract][Full Text] [Related]
11. Case Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With
Liu H; Shen Q; Chang CC; Hu S
Front Oncol; 2021; 11():795330. PubMed ID: 35004320
[TBL] [Abstract][Full Text] [Related]
12. Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity.
Yang XG; Zhu LC; Wang YJ; Li YY; Wang D
Front Oncol; 2019; 9():887. PubMed ID: 31552191
[TBL] [Abstract][Full Text] [Related]
13. Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate Cancers.
Soundararajan R; Aparicio AM; Logothetis CJ; Mani SA; Maity SN
Front Oncol; 2018; 8():69. PubMed ID: 29600194
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistance.
Luo M; Brooks M; Wicha MS
Curr Pharm Des; 2015; 21(10):1301-10. PubMed ID: 25506895
[TBL] [Abstract][Full Text] [Related]
15. Update on Epithelial-Mesenchymal Plasticity in Cancer Progression.
Fontana R; Mestre-Farrera A; Yang J
Annu Rev Pathol; 2024 Jan; 19():133-156. PubMed ID: 37758242
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis.
Lu W; Kang Y
Dev Cell; 2019 May; 49(3):361-374. PubMed ID: 31063755
[TBL] [Abstract][Full Text] [Related]
17. The Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage Plasticity.
Storck WK; May AM; Westbrook TC; Duan Z; Morrissey C; Yates JA; Alumkal JJ
Front Endocrinol (Lausanne); 2022; 13():926585. PubMed ID: 35909568
[TBL] [Abstract][Full Text] [Related]
18. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
Jolly MK; Somarelli JA; Sheth M; Biddle A; Tripathi SC; Armstrong AJ; Hanash SM; Bapat SA; Rangarajan A; Levine H
Pharmacol Ther; 2019 Feb; 194():161-184. PubMed ID: 30268772
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States.
Bornes L; Belthier G; van Rheenen J
J Clin Med; 2021 May; 10(11):. PubMed ID: 34072345
[TBL] [Abstract][Full Text] [Related]
20. Transcription networks rewire gene repertoire to coordinate cellular reprograming in prostate cancer.
Manzar N; Ganguly P; Khan UK; Ateeq B
Semin Cancer Biol; 2023 Feb; 89():76-91. PubMed ID: 36702449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]